<DOC>
	<DOCNO>NCT02270450</DOCNO>
	<brief_summary>This partially randomized clinical trial study surgery non-surgical management treat patient intra-abdominal cancer bowel obstruction . Bowel obstruction common problem advance cancer patient negatively affect quality life . It yet know whether surgery non-surgical management best treatment option bowel obstruction lead well quality life .</brief_summary>
	<brief_title>S1316 , Surgery Non-Surgical Management Treating Patients With Intra-Abdominal Cancer Bowel Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Intestinal Obstruction</mesh_term>
	<criteria>Patient must malignant bowel obstruction ( MBO ) evidence follow : Clinical evidence bowel obstruction ( via history , physical , radiographic examination ) Bowel obstruction ( distal ) ligament Treitz Intraabdominal primary cancer incurable disease Patients must malignant bowel obstruction due intraabdominal primary cancer ( i.e . stomach , small bowel [ include duodenum ] , pancreas , colon , rectum , appendiceal , ovarian , uterine , cervical , kidney , bladder , prostate , gastrointestinal stromal tumor [ GIST ] [ sit ] , sarcoma ) Patient must able tolerate major surgical procedure base clinical evaluation , status cancer , underlie medical problem A member patient 's surgical team must indicate equipoise benefit surgical treatment MBO ; surgeon must respond `` Yes '' follow question sign S1316 Surgical Equipoise Documentation form patient eligible : Is surgery treatment malignant bowel obstruction ( MBO ) consider patient ? Do equipoise ( If treat team find operation require [ e.g. , acute abdomen ] , would offer patient operation [ e.g. , patient weak tolerate surgery ] , equipoise ) ? Patients must sign bowel perforation `` acute '' abdomen evidence free air radiologic image peritonitis physical exam within 2 day prior registration Patients must register study within 3 day surgical consult MBO prior treatment ( surgical nonsurgical ) MBO Patients must Zubrod performance status 02 within 7 day prior registration Serum albumin must plan collected admission , prior treatment Patients must able complete study questionnaire English Patients legally authorize representative must inform investigational nature study must sign give write informed consent accordance institutional federal guideline As part Oncology Patient Enrollment Network ( OPEN ) registration process treat institution 's identity provide order ensure current ( within 365 day ) date institutional review board approval study enter system Patients must consent provide contact information representative monthly 24hour dietary recall phone call conduct Arizona Diet , Behavior Quality Life Assessment Lab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>